Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Christine Falcoz"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Christine Falcoz, Serge Guzy, Jana Kovač, Isabel Meister, Jean Coulibaly, Somphou Sayasone, David Wesche, Yu-Wei Lin, Jennifer Keiser
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics. 49(3)
Racemic praziquantel (PZQ) is the standard treatment for schistosomiasis and liver fluke infections (opisthorchiasis and clonorchiasis). The development of an optimal pediatric formulation and dose selection would benefit from a population pharmacoki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6cae201ddef06027fb5df8799ca7db0
https://pubmed.ncbi.nlm.nih.gov/35119619
https://pubmed.ncbi.nlm.nih.gov/35119619
Autor:
Christine Falcoz, Serge Guzy, Jana Kovač, Isabel Meister, Jean Coulibaly, Somphou Sayasone, David Wesche, Yu-Wei Lin, Jennifer Keiser
Publikováno v:
Journal of Pharmacokinetics and Pharmacodynamics. 49:395-395
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98c5eb92b14cd8854d8af589eaaa864b
https://doi.org/10.1007/s10928-022-09807-x
https://doi.org/10.1007/s10928-022-09807-x
Autor:
Jean T. Coulibaly, Isabel Meister, Jana Kovač, Christine Falcoz, Jennifer Keiser, Anna Neodo, Gordana Panic
Publikováno v:
Antimicrobial agents and chemotherapy. 62(8)
There is a growing consensus to include preschool-aged children in preventive chemotherapy programs with praziquantel to improve schistosomiasis control. However, pharmacokinetic data, crucial to establish a safe and effective dose for this age group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05787a28cdeb614df6ab3410e1009aac
https://pubmed.ncbi.nlm.nih.gov/29866859
https://pubmed.ncbi.nlm.nih.gov/29866859
Autor:
William T. Prince, Christine Falcoz, Scott D. Studenberg, Timothy C. Hardman, Julian Jenkins, Carole Bye, H. Fuder, Kathy B. Kenney
Publikováno v:
The Journal of Clinical Pharmacology. 42:887-898
These two Phase I, open-label, single-dose, randomized, crossoverstudies in 40 healthymale subjects investigated the pharmacokinetic and safety profiles of various formulations of the amprenavir prodrug GW433908 in the presence and absence of food co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b570b6e7e5a04e536162d42f2374c2b4
https://doi.org/10.1177/009127002401102803
https://doi.org/10.1177/009127002401102803
Publikováno v:
Drug Information Journal. 35:1047-1063
Computer-assisted drug development (CADD) is a knowledge-based process that integrates newly collected information in a drug/disease-specific knowledge frame and provides a rational basis for decision making during drug development. A mathematical mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61be785c0eb3b61ee22782e02b4e281d
https://doi.org/10.1177/009286150103500403
https://doi.org/10.1177/009286150103500403
Publikováno v:
Clinical Pharmacokinetics. 39:1-8
The aim of this analysis was to assess the rate and extent of systemic availability of inhaled fluticasone propionate (FP) from 2 dry powder systems (Diskhaler and Diskus) and a metered-dose inhaler (MDI) by deconvolution analysis.The inhalation devi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d615e2ccbf94e8f908709eb0fc5a3b4
https://doi.org/10.2165/00003088-200039001-00001
https://doi.org/10.2165/00003088-200039001-00001
Autor:
Alan Bye, Jo E. McDowall, Pietro Ventresca, Christine Falcoz, Ruth Oliver, Peter T. Daley-Yates
Publikováno v:
Clinical Pharmacokinetics. 39:9-15
The aim of this study was to determine the absolute oral bioavailability of fluticasone propionate (FP) in healthy volunteers.A 3-period incomplete block crossover design was used. On separate occasions, 21 male volunteers received a single 250 micro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76397911bbe905a881f7eaad2c15bd75
https://doi.org/10.2165/00003088-200039001-00002
https://doi.org/10.2165/00003088-200039001-00002
Autor:
Christine Falcoz, M. Wagner, Heike Weisser, Jürgen Barth, Michael Krieg, Ricarda Stöckmann, Hartmut Derendorf, Helmut Möllmann, Günther Hochhaus, Bernd Meibohm
Publikováno v:
European Journal of Clinical Pharmacology. 53:459-467
To evaluate the pharmacokinetic and systemic pharmacodynamic properties of inhaled fluticasone propionate (FP).Single doses of 0.25, 0.5, 1.0 and 3.0 mg FP were administered to groups of six healthy subjects. Serum concentration profiles of FP were m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e98d37a97043d43c2712ea8b2ee474d
https://doi.org/10.1007/s002280050407
https://doi.org/10.1007/s002280050407
Autor:
Ricarda Stöckmann, Helmut Möllmann, Christine Falcoz, Caroline Lawlor, Yufei Tang, Michael Krieg, Hartmut Derendorf, Hristina Dimova, Günther Hochhaus, Sriram Krishnaswami, Jürgen Barth, Peter T. Daley-Yates, A.C. Möllmann, M. Wagner
Publikováno v:
Journal of clinical pharmacology. 41(12)
Direct comparisons of the pharmacokinetic (PK) and systemic pharmacodynamic (PD) properties of inhaled corticosteroids after single and multiple dosing in the same subjects are scarce. The objective of this study was to compare thePK/PDproperties of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::769aa771666cac07dd0c3266e3c03080
https://pubmed.ncbi.nlm.nih.gov/11762560
https://pubmed.ncbi.nlm.nih.gov/11762560